Amorolfine is a broad spectrum antimycotic. Amorolfine belongs to a new chemical class, and its fungicidal action is based on an alteration of the fungal cell membrane targeted primarily on sterol biosynthesis. The ergosterol content is reduced, and at the same time unusual sterically nonplanar sterols accumulate.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Amorolfine is the active ingredient of these drugs:
Hong Kong
Austria
Poland
Australia
Hong Kong
Hong Kong Ireland
Brazil
Romania
Estonia Lithuania
Austria
Lithuania Poland
Lithuania
Australia Austria Brazil Cyprus Ecuador
Spain
Hong Kong
Brazil
Australia New Zealand
Poland
South Africa
Spain
United Kingdom
Brazil
Turkey
Brazil
New Zealand South Africa
New Zealand
Hong Kong
Ireland
Brazil
Hong Kong